BioCentury | Nov 8, 2019
Financial News

eGenesis pushes to bring pig organ transplants to humans with $100M series B

...Iannone and Fresenius’ Al Wiegman will also join the board. Yang and Church also formed Hangzhou Qihan Bio Inc....
BioCentury | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

...raises $25.5M series A+ round After raising a $7.8 million series A round in 2018, Hangzhou Qihan Bio Inc....
BioCentury | Jul 27, 2018
Financial News

Chinese xenotransplantation company Qihan grabs $7.8M series A

...immune compatibility by modifying genes in pig cells involved in immunogenicity (see "CRISPR Pigs" ). Hangzhou Qihan Bio Inc....
Items per page:
1 - 3 of 3
BioCentury | Nov 8, 2019
Financial News

eGenesis pushes to bring pig organ transplants to humans with $100M series B

...Iannone and Fresenius’ Al Wiegman will also join the board. Yang and Church also formed Hangzhou Qihan Bio Inc....
BioCentury | Sep 23, 2019
Financial News

Sept. 23 Financial Quick Takes: Innate looks to add U.S. listing; plus Curamir's launch, Qihan Bio and Vedanta

...raises $25.5M series A+ round After raising a $7.8 million series A round in 2018, Hangzhou Qihan Bio Inc....
BioCentury | Jul 27, 2018
Financial News

Chinese xenotransplantation company Qihan grabs $7.8M series A

...immune compatibility by modifying genes in pig cells involved in immunogenicity (see "CRISPR Pigs" ). Hangzhou Qihan Bio Inc....
Items per page:
1 - 3 of 3